Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
Rest assured, competitors Deloitte, Ernst & Young, and PricewaterhouseCoopers are likely to follow in KPMG’s tracks.
For the crypto industry, President Trump is something of an enigma. But the launch of the Trump family coins was a bit, well, embarrassing.
President Donald Trump used the first hours of his second term in office Monday to make the emergency declaration.